Drug Shortage Report for CARDIOLITE
Report ID | 142747 |
Drug Identification Number | 02328003 |
Brand name | CARDIOLITE |
Common or Proper name | Kit for the Preparation of Technetium Tc99m Sestamibi for Injection |
Company Name | LANTHEUS MI CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | TETRAKIS [CU |
Strength(s) | 1MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | Kits of 2, 5, 20, or 30 vials |
ATC code | V09GX |
ATC description | |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2021-09-01 |
Actual start date | 2021-08-27 |
Estimated end date | 2022-02-15 |
Actual end date | 2022-02-21 |
Shortage status | Resolved |
Updated date | 2022-02-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1111 DR. FREDERIK-PHILIPS BLVD., SUITE 600 MONTREAL, QUEBEC CANADA H4M 2X6 |
Company contact information | lmicanada@lantheus.com 1-800-811-5500 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2022-02-22 | French | Compare |
v10 | 2022-02-22 | English | Compare |
v9 | 2022-01-14 | French | Compare |
v8 | 2022-01-14 | English | Compare |
v7 | 2021-10-18 | French | Compare |
v6 | 2021-10-18 | English | Compare |
v5 | 2021-09-02 | English | Compare |
v4 | 2021-07-19 | French | Compare |
v3 | 2021-07-19 | English | Compare |
v2 | 2021-07-19 | French | Compare |
v1 | 2021-07-19 | English | Compare |
Showing 1 to 11 of 11